Clinical Trials Logo

Severe Sepsis With Septic Shock clinical trials

View clinical trials related to Severe Sepsis With Septic Shock.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02797431 Terminated - Clinical trials for Severe Sepsis With Septic Shock

Immune Reconstitution of Immunosuppressed Sepsis Patients

IRIS-7a
Start date: January 14, 2016
Phase: Phase 2
Study type: Interventional

A multicenter, randomized, double-blinded, placebo-controlled study of two dosing frequencies of recombinant Interleukin-7 (CYT107) treatment to restore absolute lymphocyte counts in sepsis patients; IRIS-7A (Immune Reconstitution of Immunosuppressed Sepsis patients). A parallel study will be performed in United State of America to allow a common statistical analysis of the primary end points and analysis for the enrolled patient population.